Replies to post #99077 on Anavex Life Sciences Corp (AVXL)

[hessmessinc]

Be careful pointing out that it was possible to see that we weren't getting 15-month data at this past conference.

Posters who did that before the conference were called several negative names and were told they were only spreading FUD.

[A_Good_Day_2]

I already had considered everything you say. My point is that, at this point there is no possibility of the 2a data "going bad" because the trial completed. The extension doesn't really bear at all on the spectacular results that the originally planned trial produced. It was a complete success and that cannot change.

Now we move on to 2/3. As we continue to record more long-term results of the extension trial it will make approval smoother and quite possibly quicker.